Immunotherapy Updates in Advanced Hepatocellular Carcinoma

SIMPLE SUMMARY: Advanced hepatocellular carcinoma (HCC) carries a grim prognosis, which has historically been compounded by a lack of available systemic therapies. Sorafenib monotherapy was the standard of care for front-line treatment of advanced HCC for many years, despite both poor tolerability a...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Amisha, Beechinor, Ryan J., Huynh, Jasmine C., Li, Daneng, Dayyani, Farshid, Valerin, Jennifer B., Hendifar, Andrew, Gong, Jun, Cho, May
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125389/
https://www.ncbi.nlm.nih.gov/pubmed/33946408
http://dx.doi.org/10.3390/cancers13092164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125389/
https://www.ncbi.nlm.nih.gov/pubmed/33946408
http://dx.doi.org/10.3390/cancers13092164

Ejemplares similares